Clinical trial
Evaluation of the Efficacy and Safety of the Multistrain Probiotic "BioAmicus Complete" in Improving Gastrointestinal Symptoms in Children Aged 0-24 Months: A Randomized, Open-Label, Parallel-Group, Controlled Trial
NCT07148583 is registered in ClinicalTrials.gov with Haiphong University of Medicine and Pharmacy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy and Safety of the Multistrain Probiotic "BioAmicus Complete" in Improving Gastrointestinal Symptoms in Children Aged 0-24 Months: A Randomized, Open-Label, Parallel-Group, Controlled Trial
- Lead sponsor
- Haiphong University of Medicine and Pharmacy
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 5, 2025
- Completion date
- May 30, 2026
- Enrollment
- 110 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dysbiosis, functional constipation, functional diarrhea, gastroesophageal reflux (ger), infantile colic